Earlier this month, Vitor Belfort avenged an old loss with a 77 second TKO over Dan Henderson at UFC Fight Night 32 in a Light Heavyweight fight. The victory was his third consecutive knockout of the year over top 10 competition. UFC president Dana White granted him prime position as the next to fight for the Middleweight title after champion Chris Weidman rematches Anderson Silva in December.
It's well known that Belfort has been competing with an exemption for the controversial testosterone replacement therapy. He revealed recently that he's been undergoing the treatment for three years now, putting his start around the same time as his last 185 lb. title shot at UFC 126.
In a recent interview with MMA Fighting, Belfort was non-committal regarding whether or not he was on TRT for that fight.
"When was that fight? I don’t remember when I started my treatment, actually," he said. "But I believe it was around that time."
With the news out that Vitor and everyone else at Fight Night 32 passed their pre- and post-fight drug tests, he also discussed his testosterone levels from that night:
"My (testosterone) levels were low in my last fight," Belfort told MMAFighting.com during a media scrum in his gym in Rio de Janeiro, Brazil. "I have all the exams to prove that I have a disease. It’s simple."
Brazilian MMA Athletic Commission’s medical director Dr. Marcio Tannure explained to MMAFighting.com that one of Belfort's pre-fight tests were below the normal limits, but that's "legal."
Additionally, Belfort is confident he would be granted a therapeutic use exemption (TUE) by the NSAC if the UFC chose to have him fight in Las Vegas for the title.